Wilmington Savings Fund Society’s AstraZeneca AZN Stock Holding History

Wilmington Savings Fund Society’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.23M	Buy	32,878 +170	+0.5%	+$32K	0.14%	117
2026 Q1	$6.45M	Sell	32,708 -517	-2%	-$99.7K	0.15%	113
2025 Q4	$6.11M	Buy	33,225 +106	+0.3%	+$18.6K	0.14%	117
2025 Q3	$5.08M	Sell	33,119 -5,447	-14%	-$824K	0.12%	140
2025 Q2	$5.39M	Buy	38,566 +85	+0.2%	+$11.9K	0.1%	167
2025 Q1	$5.66M	Buy	38,481 +655	+2%	+$94.8K	0.11%	157
2024 Q4	$4.96M	Buy	37,826 +2,002	+6%	+$280K	0.09%	182
2024 Q3	$5.58M	Buy	+35,824	New	+$5.78M	0.1%	167

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wilmington Savings Fund Society's AZN Position: Q2 2026 in Review

Wilmington Savings Fund Society increased its AstraZeneca (AZN) stake by 0.52% in Q2 2026, buying an estimated $32K and bringing the position to 32,878 shares worth $6.23M. The position accounts for 0.14% of the portfolio, ranked #117.

Wilmington Savings Fund Society first reported a position in AZN in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.45M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Wilmington Savings Fund Society held 32,878 shares of AstraZeneca worth $6.23M as of Q2 2026.
Wilmington Savings Fund Society bought 170 AstraZeneca shares in Q2 2026, an estimated $32K.
AstraZeneca made up 0.14% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #117 holding.
Wilmington Savings Fund Society first reported a position in AstraZeneca in Q3 2024 and has held it in 8 quarters since.
Wilmington Savings Fund Society's AstraZeneca position peaked at $6.45M in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.